Home
MRNA
MRNA News

Latest Moderna Inc. (MRNA) News on April 2, 2025

5 Things to Know Before the Stock Market Opens

Investopedia

19 hours ago

5 Things to Know Before the Stock Market Opens

Watch These Moderna Price Levels as Stock Sinks to 5-Year Low

Investopedia

a day ago

Watch These Moderna Price Levels as Stock Sinks to 5-Year Low

S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official

Investopedia

a day ago

S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official

Moderna (MRNA) Stock Trades Down, Here Is Why

StockStory

a day ago

Moderna (MRNA) Stock Trades Down, Here Is Why

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Investor's Business Daily

a day ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

MT Newswires

a day ago

US Equities Markets End Mixed Monday Ahead of Reciprocal Tariff Announcements

MT Newswires

2 days ago

Top Midday Decliners

Why Moderna Stock Is Plummeting Today

Motley Fool

2 days ago

Why Moderna Stock Is Plummeting Today

MT Newswires

2 days ago

Moderna's RSV Vaccine Receives Approval in Australia

ACCESS Newswire

2 days ago

Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments

Insider Monkey

3 days ago

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Investor's Business Daily

4 days ago

China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them!

Insider Monkey

6 days ago

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them!

Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?

Investor's Business Daily

6 days ago

Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?

U.S. to end funding for child vaccines in developing countries, NY Times reports

TipRanks

6 days ago

U.S. to end funding for child vaccines in developing countries, NY Times reports

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears

Insider Monkey

6 days ago

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious

Barrons.com

6 days ago

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious

Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

7 days ago

Is Moderna, Inc. (MRNA) a Promising Biotech Stock According to Wall Street Analysts

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025

Insider Monkey

9 days ago

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

StockStory

9 days ago

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

Moderna price target lowered to $33 from $40 at JPMorgan

TipRanks

11 days ago

Moderna price target lowered to $33 from $40 at JPMorgan

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Motley Fool

11 days ago

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

11 days ago

Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It

Argus Research

12 days ago

Analyst Report: Moderna Inc

Argus Research

12 days ago

Market Update: CPB, NKE, WSM, CARR, MRNA

MT Newswires

12 days ago

JPMorgan Cuts Price Target on Moderna to $33 From $40, Maintains Underweight Rating

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

StockStory

12 days ago

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

4 Things You Need to Know if You Buy Moderna Stock Today

Motley Fool

13 days ago

4 Things You Need to Know if You Buy Moderna Stock Today

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

13 days ago

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

2 No-Brainer Biotech Stocks to Buy Right Now

Motley Fool

13 days ago

2 No-Brainer Biotech Stocks to Buy Right Now

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

StockStory

14 days ago

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

Vaccine makers face mRNA backlash as states seek further restrictions

Pharma Voice

14 days ago

Vaccine makers face mRNA backlash as states seek further restrictions

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Zacks

15 days ago

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

MT Newswires

15 days ago

Bernstein Adjusts Price Target on Moderna to $39 From $45, Keeps Market Perform Rating

Moderna (MRNA) Advances But Underperforms Market: Key Facts

Zacks

15 days ago

Moderna (MRNA) Advances But Underperforms Market: Key Facts

Down 93%, Is It Finally Time to Buy Moderna?

Motley Fool

18 days ago

Down 93%, Is It Finally Time to Buy Moderna?

Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?

GuruFocus.com

19 days ago

Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?

Investing.com

20 days ago

Citi says SMid biotechs alternative to large caps as it starts coverage

MT Newswires

20 days ago

Citigroup Initiates Moderna at Neutral With $40 Price Target

Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges

Simply Wall St.

21 days ago

Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges

3 Reasons MRNA is Risky and 1 Stock to Buy Instead

StockStory

21 days ago

3 Reasons MRNA is Risky and 1 Stock to Buy Instead

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

StockStory

22 days ago

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges

Simply Wall St.

23 days ago

Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges

3 CEOs Just Spent Millions Buying Their Beaten-Down Stock

Barrons.com

24 days ago

3 CEOs Just Spent Millions Buying Their Beaten-Down Stock

CDC plans study into potential vaccines, autism connections, Reuters reports

TipRanks

25 days ago

CDC plans study into potential vaccines, autism connections, Reuters reports

Why Moderna Stock Has Surged 15% This Week Despite Mixed News

Investor's Business Daily

25 days ago

Why Moderna Stock Has Surged 15% This Week Despite Mixed News

Moderna (NasdaqGS:MRNA) Rises 10% Despite US$1 Billion Revenue Drop Prediction

Simply Wall St.

a month ago

Moderna (NasdaqGS:MRNA) Rises 10% Despite US$1 Billion Revenue Drop Prediction

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Zacks

a month ago

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

Zacks

a month ago

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

MT Newswires

a month ago

Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court

Here's Why Moderna Stock Soared 16% on Wednesday

Zacks

a month ago

Here's Why Moderna Stock Soared 16% on Wednesday

Why Moderna, Inc. (MRNA) Went Up on Wednesday

Insider Monkey

a month ago

Why Moderna, Inc. (MRNA) Went Up on Wednesday

MT Newswires

a month ago

Berenberg Adjusts Price Target on Moderna to $30 From $33, Keeps Hold Rating

Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday

Motley Fool

a month ago

Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday

S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism

Investopedia

a month ago

S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

The Dow surges 500 points as Trump hands out some tariff relief

Quartz

a month ago

The Dow surges 500 points as Trump hands out some tariff relief

MT Newswires

a month ago

Equity Markets Rise as Trump Exempts Auto Makers From Tariffs

MT Newswires

a month ago

Sector Update: Health Care

MT Newswires

a month ago

Redburn Atlantic Adjusts Price Target on Moderna to $55 From $73, Maintains Neutral Rating

Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80%

Motley Fool

a month ago

Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80%

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

StockStory

a month ago

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

MT Newswires

a month ago

Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement

Moderna receives MHRA marketing authorization for RSV vaccine

TipRanks

a month ago

Moderna receives MHRA marketing authorization for RSV vaccine

MT Newswires

a month ago

Moderna Gets UK Marketing Authorization for RSV Vaccine

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

ACCESS Newswire

a month ago

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

1 Healthcare Stock to Own for Decades and 2 to Ignore

StockStory

a month ago

1 Healthcare Stock to Own for Decades and 2 to Ignore

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool

a month ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Moderna Stock Slumps 7% On A Surprise Twist In The RFK Jr. Saga

Investor's Business Daily

a month ago

Moderna Stock Slumps 7% On A Surprise Twist In The RFK Jr. Saga

These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More

Barrons.com

a month ago

These Stocks Moved the Most Today: Nvidia, Super Micro, Snowflake, Moderna, Tesla, Salesforce, Vistra, and More

Health dept. reviewing bird flu vaccine deal with Moderna: RPT

Yahoo Finance Video

a month ago

Health dept. reviewing bird flu vaccine deal with Moderna: RPT

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Motley Fool

a month ago

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine

Bloomberg

a month ago

Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine

Moderna's bird flu vaccine has a problem

Quartz

a month ago

Moderna's bird flu vaccine has a problem

These Stocks Are Moving the Most Today: Nvidia, Snowflake, Tesla, Moderna, Salesforce, Super Micro, Vistra, and More

Barrons.com

a month ago

These Stocks Are Moving the Most Today: Nvidia, Snowflake, Tesla, Moderna, Salesforce, Super Micro, Vistra, and More

MT Newswires

a month ago

Market Chatter: Trump Administration Reviewing Moderna Bird Flu Vaccine Contract Amid Spending Scrutiny

Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract

Barrons.com

a month ago

Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract

Moderna, Inc. (MRNA): A Bull Case Theory

Insider Monkey

a month ago

Moderna, Inc. (MRNA): A Bull Case Theory

Moderna, Inc. (MRNA): Among the Best Vaccine Stocks to Buy According to Hedge Funds

Insider Monkey

a month ago

Moderna, Inc. (MRNA): Among the Best Vaccine Stocks to Buy According to Hedge Funds

MT Newswires

a month ago

Deutsche Bank Adjusts Moderna Price Target to $35 From $46, Maintains Hold Rating

Moderna to Present at Upcoming Conferences in March 2025

ACCESS Newswire

a month ago

Moderna to Present at Upcoming Conferences in March 2025

Moderna (MRNA) International Revenue Performance Explored

Zacks

a month ago

Moderna (MRNA) International Revenue Performance Explored

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Zacks

a month ago

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus

Insider Monkey

a month ago

Why Moderna Inc. (MRNA) Surged On Friday?

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China

Investopedia

a month ago

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

Motley Fool

a month ago

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

MT Newswires

a month ago

UBS Adjusts Moderna Price Target to $78 From $96, Maintains Buy Rating

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Zacks

a month ago

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Yahoo Finance

a month ago

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Why Moderna (MRNA) Went Up on Tuesday?

Insider Monkey

a month ago

Why Moderna (MRNA) Went Up on Tuesday?

Challenges mount for vaccine makers

Pharma Voice

a month ago

Challenges mount for vaccine makers

Why Moderna (MRNA) Stock Is Up Today

StockStory

a month ago

Why Moderna (MRNA) Stock Is Up Today

Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook

GuruFocus.com

a month ago

Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook

Investing.com

a month ago

Moderna has limited upside: Barclays

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?

Zacks

a month ago

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?

Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?

Investor's Business Daily

a month ago

Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?

MT Newswires

a month ago

Barclays Downgrades Moderna to Equalweight From Overweight, Adjusts Price Target to $45 From $111

First Cows, Now Cats. Is Bird Flu Coming for Humans Next?

The Wall Street Journal

a month ago

First Cows, Now Cats. Is Bird Flu Coming for Humans Next?

Moderna reports decline in Q4 2024 revenue

Pharmaceutical Technology

a month ago

Moderna reports decline in Q4 2024 revenue

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

GuruFocus.com

2 months ago

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

Share on Social Networks: